Document is current
Any future updates will be listed below
-
Authors
Lanfranchi, Marine
Yandiev, Sozerko
Meyer-Dilhet, Géraldine
Ellouze, Salma
Kerkhofs, Martijn
Dos Reis, Raphael
Garcia, Audrey
Blondet, Camille
Amar, Alizée
Kneppers, Anita https://orcid.org/0000-0003-4901-5468
Polvèche, Hélène
Plassard, Damien https://orcid.org/0000-0001-8569-6163
Foretz, Marc https://orcid.org/0000-0001-7017-9032
Viollet, Benoit https://orcid.org/0000-0002-0121-0224
Sakamoto, Kei https://orcid.org/0000-0001-8839-5980
Mounier, Rémi
Bourgeois, Cyril F. https://orcid.org/0000-0002-0756-5501
Raineteau, Olivier
Goillot, Evelyne
Courchet, Julien https://orcid.org/0000-0002-1199-9329
- License Information
-
More Information
Article History
Received: 25 March 2023
Accepted: 15 February 2024
First Online: 21 March 2024
Competing interests
: A patent application EP 23 305 322 entitled “BRAWNIN AGONISTS FOR USE IN THE TREATMENT OF AXONAL METABOLIC DISORDERS” was filed on March 9, 2023 (S.Y. and J.C.). The remaining authors have no competing interests.
